Project Details
Description
A 36-week, single-group, open-label study to evaluate the safety and tolerability of ferric citrate in children with hyperphosphatemia related to chronic kidney disease.
| Status | Active |
|---|---|
| Effective start/end date | 1/4/21 → 10/31/25 |
Funding
- AKEBIA THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.